ATE200622T1 - Verwendung von hydantoin-derivaten zur herstellung eines medikaments zur behandlung von krankheiten in zusammenhang mit aktivem sauestoff und freien radikalen - Google Patents

Verwendung von hydantoin-derivaten zur herstellung eines medikaments zur behandlung von krankheiten in zusammenhang mit aktivem sauestoff und freien radikalen

Info

Publication number
ATE200622T1
ATE200622T1 AT96120597T AT96120597T ATE200622T1 AT E200622 T1 ATE200622 T1 AT E200622T1 AT 96120597 T AT96120597 T AT 96120597T AT 96120597 T AT96120597 T AT 96120597T AT E200622 T1 ATE200622 T1 AT E200622T1
Authority
AT
Austria
Prior art keywords
diseases
free radicals
active oxygen
group
medication
Prior art date
Application number
AT96120597T
Other languages
English (en)
Inventor
Hitoshi Endou
Kazuharu Ienaga
Cho
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Application granted granted Critical
Publication of ATE200622T1 publication Critical patent/ATE200622T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT96120597T 1995-12-20 1996-12-20 Verwendung von hydantoin-derivaten zur herstellung eines medikaments zur behandlung von krankheiten in zusammenhang mit aktivem sauestoff und freien radikalen ATE200622T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34983195 1995-12-20

Publications (1)

Publication Number Publication Date
ATE200622T1 true ATE200622T1 (de) 2001-05-15

Family

ID=18406411

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96120597T ATE200622T1 (de) 1995-12-20 1996-12-20 Verwendung von hydantoin-derivaten zur herstellung eines medikaments zur behandlung von krankheiten in zusammenhang mit aktivem sauestoff und freien radikalen

Country Status (11)

Country Link
US (1) US6197806B1 (de)
EP (1) EP0780125B1 (de)
KR (1) KR100468109B1 (de)
CN (1) CN1093401C (de)
AT (1) ATE200622T1 (de)
AU (1) AU705447B2 (de)
CA (1) CA2193551C (de)
DE (1) DE69612540T2 (de)
DK (1) DK0780125T3 (de)
ES (1) ES2158223T3 (de)
TW (1) TW461814B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU775606B2 (en) * 1998-08-31 2004-08-05 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
AU754989B2 (en) * 1998-11-16 2002-11-28 Nippon Zoki Pharmaceutical Co., Ltd. A therapeutic agent for intractable vasculitis
JP4711523B2 (ja) * 2001-02-13 2011-06-29 日本臓器製薬株式会社 低アルブミン血症改善剤
US6919365B2 (en) 2001-04-11 2005-07-19 Senju Pharmaceutical Co., Ltd. Imidazolidinedione derivatives and use thereof as drugs
ATE417611T1 (de) * 2001-11-19 2009-01-15 Medigene Ag Arzneimittel zur behandlung von viralen haut- und tumorerkrankungen
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
US20060241163A1 (en) * 2005-04-20 2006-10-26 Kaoru Okamoto Optically active (S)-hydantoin derivative
US20060241162A1 (en) * 2005-04-20 2006-10-26 Kaoru Okamoto Optically active (R)-hydantoin derivative
CN101732348B (zh) 2008-11-11 2015-01-14 威世药业（如皋）有限公司 牛痘疫苗致炎兔皮提取物在制备急性脑血管疾病治疗药物中的用途
BRPI1107312B1 (pt) * 2011-11-25 2021-09-08 Universidade Federal De Santa Catarina Composto de acil-hidrazona
EP2801573A1 (de) * 2013-05-09 2014-11-12 Sanofi Hydantoinderivate als CD38-Hemmer
CN103360320B (zh) * 2013-07-30 2015-12-02 邱智东 1-甲基海因的制备方法
EP3639821B1 (de) * 2017-06-13 2024-08-28 National Cancer Center Karzinogenese-inhibitor

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4099007A (en) 1969-04-02 1978-07-04 Hoechst Aktiengesellschaft N,n-substituted 2,4,5-triketoimidazolidines and a process for their preparation
US3818031A (en) 1971-03-26 1974-06-18 Ciba Geigy Corp Imidazolidinetrionecarboxylic acid derivatives
IL39042A (en) 1971-03-26 1976-04-30 Ciba Geigy Ag 2,4,5-trioxoimidazolidine-1-carboxylic acid derivatives,their preparation and their use for the control of plant metabolism
CH563711A5 (en) 1972-03-03 1975-07-15 Ciba Geigy Ag Agents for regulating plant metabolism - contg. imidazolidine-2,4,5-trione-3-carboxylic acid derivs.
DE2612926A1 (de) 1976-03-26 1977-10-06 Boehringer Mannheim Gmbh Neue acyl-derivate der 6-(alpha- amino-phenylacetamido)-penicillansaeure
JPH0686436B2 (ja) 1984-11-15 1994-11-02 日本臓器製薬株式会社 新規ヒダントイン誘導体及び該化合物を含有する医薬組成物
AU578068B2 (en) 1984-03-08 1988-10-13 Nippon Zoki Pharmaceutical Co., Ltd. Hydantoin derivatives and pharmaceutical compositions containing them
US4832682A (en) 1984-08-08 1989-05-23 Survival Technology, Inc. Injection method and apparatus with electrical blood absorbing stimulation
US4658830A (en) 1984-08-08 1987-04-21 Survival Technology, Inc. Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms
US4656034A (en) 1985-05-20 1987-04-07 Survival Technology, Inc. Absorption enhancing agents
AU4674385A (en) 1984-08-08 1986-03-07 Survival Technology Inc. Absorption enhancing agents
US4661469A (en) 1984-08-08 1987-04-28 Survival Technology, Inc. t-PA composition capable of being absorbed into the blood stream and method of administration
US5078680A (en) 1984-08-08 1992-01-07 Survival Technology, Inc. Automatic injector for emergency treatment
US5340829A (en) * 1984-11-20 1994-08-23 Washington Research Foundation Immunoregulatory agents
JPH0764729B2 (ja) 1985-02-06 1995-07-12 日本臓器製薬株式会社 イミダゾリジントリオン誘導体を含有する医薬組成物
DE3668888D1 (de) 1985-02-06 1990-03-15 Nippon Zoki Pharmaceutical Co Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
JP2567593B2 (ja) 1986-12-29 1996-12-25 日本臓器製薬株式会社 イミダゾリジントリオン誘導体及び該化合物を有効成分として含有するアレルギ−性疾患治療剤
JPS6456614A (en) 1987-08-27 1989-03-03 Ono Pharmaceutical Co Maillard reaction inhibitor
JPH01156965A (ja) 1987-09-29 1989-06-20 Taiho Yakuhin Kogyo Kk チオヒダントイン化合物
JP2544183B2 (ja) 1988-07-29 1996-10-16 日本臓器製薬株式会社 新規パラバン酸誘導体及び該化合物を有効成分として含有する医薬組成物
JP2817219B2 (ja) 1988-09-08 1998-10-30 武田薬品工業株式会社 カルバジン酸誘導体、その製造法及び製剤
JPH02225485A (ja) 1989-02-27 1990-09-07 Taiho Yakuhin Kogyo Kk チエノピリミジン―３―酢酸誘導体
CA2011899A1 (en) 1989-03-13 1990-09-13 Masaaki Toda Benzopyran derivatives
JP2678499B2 (ja) 1989-08-09 1997-11-17 日本臓器製薬 株式会社 尿毒症毒素低下剤
JPH0667827A (ja) 1992-08-18 1994-03-11 Nec Software Ltd データ表示制御装置
JP3267698B2 (ja) 1992-10-27 2002-03-18 株式会社三和化学研究所 ヒダントイン誘導体及びその塩並びにこれらを有効成分とするメイラード反応阻害剤
JPH06305964A (ja) 1993-02-26 1994-11-01 Otsuka Pharmaceut Co Ltd メイラード反応阻害剤
DE69429641T2 (de) 1993-02-26 2002-08-29 Otsuka Pharmaceutical Co., Ltd. Thiazole oder imidazole derivate als maillard reaktion inhibitoren
AU3086095A (en) 1994-07-29 1996-03-04 Suntory Limited Imidazolidine derivative and use thereof
JPH08157473A (ja) 1994-10-06 1996-06-18 Nissan Chem Ind Ltd ピラゾール系チアゾリジン類
US5912261A (en) 1994-12-20 1999-06-15 Nippon Zoki Pharmaceutical Co., Ltd. Carboxyalkyl heterocyclic derivatives
US5681843A (en) 1994-12-20 1997-10-28 Nippon Zoki Pharmaceutical Co., Ltd. Parabanic acid derivatives

Also Published As

Publication number Publication date
EP0780125B1 (de) 2001-04-18
EP0780125A2 (de) 1997-06-25
ES2158223T3 (es) 2001-09-01
US6197806B1 (en) 2001-03-06
DE69612540D1 (de) 2001-05-23
AU705447B2 (en) 1999-05-20
TW461814B (en) 2001-11-01
DK0780125T3 (da) 2001-05-07
AU7641496A (en) 1997-06-26
DE69612540T2 (de) 2001-08-30
KR100468109B1 (ko) 2005-04-13
CA2193551A1 (en) 1997-06-21
EP0780125A3 (de) 1997-11-05
KR970032863A (ko) 1997-07-22
CN1159324A (zh) 1997-09-17
CA2193551C (en) 2006-03-21
CN1093401C (zh) 2002-10-30

Similar Documents

Publication Publication Date Title
EP1259487B8 (de) 2-aminonicotinamid-derivate und ihre verwendung als vegf-rezeptor tyrosin-kinase inhibitoren
MY101208A (en) Phenyl-piperazine anti-arrhythmia agents.
HUT50163A (en) Process for production of derivatives of indole and medical compositions containing them as active substance
ATE200622T1 (de) Verwendung von hydantoin-derivaten zur herstellung eines medikaments zur behandlung von krankheiten in zusammenhang mit aktivem sauestoff und freien radikalen
MA27582A1 (fr) Derives benzazepine pour le traitement de troubles neurologiques
NO170280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfamatderivater
TR200102136T2 (tr) Antikanser maddeleri olarak faydaı ikame-edilmiş bisiklik türevler.
TNSN99161A1 (fr) Derives de quinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TR200003478T2 (tr) Antikanser maddeleri olarak faydalı izotiyazol türevleri
EP1396493A4 (de) Heterocyclische verbindungen
AR026974A1 (es) N-[5-[[[5-alquil-2-oxazolil]metil]tio]-2-tiazolil]-carboxamidas, utiles como inhibidores de cinasas dependientes de ciclina, y las composicionesfarmaceuticas que los contienen
ATE46335T1 (de) Piperazinverbindungen als paf-antagonisten.
ATE260898T1 (de) Substituierte vinylpyridinderivate und arzneimittel, die diese enthalten
DE69429570D1 (de) Galanthamin Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente
SI1216245T1 (en) Pharmaceutically active sulfonyl hydrazide derivatives
DE69413118D1 (de) Benzolsulfonamid-Derivate zur Behandlung der Blaseninstabilität
DE69918431D1 (de) Benzofuroxanderivate und ihre verwendung zur behandlung von angina pectoris
DE68917772D1 (de) 2-Alkyl-3-benzoylbenzofurane und diese enthaltende pharmazeutische Zusammensetzungen.
DE69828516D1 (de) (hetero)aryl-sulfonamid derivate, deren herstellung und deren verwenddung als faktor xa inhibitoren
HUT57716A (en) Process for producing sulfonylamino-substituted bicyclic hydroxame acid derivatives and pharmaceutical compositions comprising such compounds
NO971743L (no) Farmasöytisk sammensetning for profylakse og behandling av type I allergiske sykdommer
FR2669030B1 (fr) Nouveaux derives d'imidazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE181503T1 (de) Verwendung von idazoxan und derivaten zur herstellung eines arzneimittels zur behandlung von parkinsonismus und seiner evolution
ITMI920082A1 (it) Derivati solforati di acidi biliari
WO2001040187A3 (en) Compound having effect of promoting neuron differentiation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee